|
Post by joeypotsandpans on Oct 20, 2020 18:58:11 GMT -5
There is a huge amount of space between "no refrigeration required" and "-90 degree freezer required". Even if a technosphere vaccine needed to be kept in a regular common refrigerator that would still be a huge advantage. That's the huge advantage of Inovio's vaccine, it does not require refrigeration
|
|
|
Post by joeypotsandpans on Sept 18, 2020 14:59:02 GMT -5
Forgot about options expiry... Someday soon, this position will start heading upward in a steady, consistent manner and there will be no looking back. Two dollars a share will be a distant memory. That day has been a long time coming and the feeling will be Oh So Good. GLTAL ChrisC Those that bought DXCM and waited patiently and now have their embarrassment of riches 👌😉👍🏻
|
|
|
Post by joeypotsandpans on Sept 14, 2020 12:32:14 GMT -5
C'mon CCI, you know it has nothing to do with that, it's because peppy said it's about to break out of the triangle on the weekly charts
|
|
|
Post by joeypotsandpans on Aug 19, 2020 11:48:36 GMT -5
at one hour of trade, real time, 333,037 summary 469,194 1.7999+0.0699 (+4.0405%) As of 10:33AM EDT. Market open. let's see if more volume comes in. $1.86 the next resistance level through $1.86, $1.95, $1.99, $2.05 joeypotsandpans eyeballs please At two hours of trade, real time volume, 1,874,547 shares summary volume, 3,228,971 Avg. Volume 3,511,262 1.9600+0.2300 (+13.29%) As of 11:30AM EDT. Market open. Price is still moving. My guess today, $2.05 Volume came in. Look where price is relative to the 200W ma, RSI on weekly also strong, let's see weekly candle confirmation of nice close and break of 200W, there are many of those like uvula that feel that $2.00 resistance
|
|
|
Post by joeypotsandpans on Aug 1, 2020 17:55:37 GMT -5
Hi, CCI, I always respect your posts! A fine effort on this last post. Without Covid, I’m confident we would be in the high 800’s in scripts. LOL. Rotten luck. I’m no Mike fan, but it’s not clear to me that anyone MNKD could reasonably hope to take his place would be any better. I completely agree Bob. About the scripts and the Covid. But I want to ask you central...... Are you going to go on record with this statement....,” Mike has the company in a place where it can survive for a long time without diluting the heck out of the shareholders.” When Bill and I went to Headquarters at Westlake it was a very sad experience..it was clear they had tried everything but that they were still swimming up hill, but tired. There’s a better way to market this drug.. at least a different way should be acknowledged. We had to prove that and we have...don’t assume there’s too much animosity:-) We all want the same thing, multiple ideas should be explored. If you wanna know how the animosity started read Steve’s posts about the overseas deals..if you want to know where things stand now read Bill’s letter. "When Bill and I went to Headquarters at Westlake it was a very sad experience..it was clear they had tried everything but that they were still swimming up hill, but tired."Hi Sports , can you expand on this part of your post? This is a very subjective perspective so was just wondering how you perceived this as a sad experience, still swimming uphill and tired. Was that your takeaway from any particular statements made? Also from a time context when was that visit. Just curious to how you came to this conclusion. Thanks in advance -J Appreciate the post CCI
|
|
|
Post by joeypotsandpans on Jul 27, 2020 13:05:36 GMT -5
Joey - there have been some people asking about COVID-19 on the facebook group. You may want to share your experience there. I'm not on facebook, so maybe someone can feel free to direct them here? Thx!
|
|
|
Post by joeypotsandpans on Jul 26, 2020 17:23:16 GMT -5
First of all N1 survives Covid-19 warrants a questionnaire. The reason is in medical statistics you must consider "severity" which tosses out basic statistics when death is the severity and you have one N1 Afrezza user reporting he survived it required to make mandatory root cause investigation. E.g.. A questionnaire to all Afrezza users to collect information directly related to the original condition Covid-19...and the Afrezza user outcomes. That is where you will see greater statistical N to do a calculation of Afrezza occurrence of Covid-19 survival. If Afrezza has high survival rates in Covid-19 cases..that would be huge..just saying..where's the questionnaire..the data?...go get it! So a poster came on here a bit irritated from the tone of their post and in a defensive manner and has to state the obvious...that I'm a sample size of 1...as peppy would say no chit sherlock. But as you state what would there be to lose in just sending out a survey to existing Afrezza users and try to obtain some more "anecdotal" evidence of a possible benefit? Rationally one might think, gee, let's see what happens if we get a sample size of 200 that might have contracted the virus and compare with a group of 200 PWD that used injectable insulin who had gotten it, etc.etc. No reason for other poster to get irritated, kind of find it amusing actually 🤔😅
|
|
|
Post by joeypotsandpans on Jul 26, 2020 9:44:07 GMT -5
The available evidence suggest that both insulin and Vitamin D exert their effects by their effects on the toll-like receptors which are usually the starting point for an severe inflammatory reaction. Vitamin D, in particular, up-regulates production of cathelicidins and defensins which are two classes of molecules that attack pathogens as part of the immune response. Neither insulin nor Vitamin D are a cure for viral pathogens, but they do help to maintain immune competency for those who would otherwise be immune compromised. The growing body of evidence is that all the people who have been exposed to COVID but who either were asymptomatic or recovered spontaneously without suffering significant effects did so through activation of T-cell responses from a healthy immune system. That is why many of these recovering patients do not test positive for antibodies, which are produced by B-cells rather than T-cells, and it also explains why COVID has a more severe set of implications for older patients because the innate ability to mount strong T-cell responses declines with age. T and B cells are both part of the immune system, but they work in different ways and B cell responses normally need T-helper cells to accomplish their effect while T-cell immunity can often do the job by itself. Either way, a strong immune system is your best defense against any pathogen. So no, Afrezza is not a magic bullet that will kill off COVID, but a healthy immune system might. If you are a diabetic and your disease is not well-controlled then now is a really good time to get it under control. If you live in a northern climate or do not get outdoors very much, a little extra Vitamin D in your diet (or via supplements) is not a bad idea either. Not that simple, my wife works ICU, the beds are full with covid, the last two weeks they lost a 23 yr and 28 yr. old, both had NO co-morbidities and who were perfectly healthy and have grown up in southern nevada where there's few days annually without sunshine. The person I contracted the disease from is 15yrs. younger than I and again no co-morbities and living in southern nevada most of his life. He ended up in hospital on oxygen for 5 days. I'm convinced it's more than a coincidence that inhaling monomeric insulin directly into my lungs played a critical role in keeping my covid under control and ultimately keeping me out of the hospital and off a ventilator. Having now read that NIH clinical study regarding the anti-inflammatory effects of insulin it now makes perfect sense that my use of Afrezza unknowingly helped my battle as a higher at risk T2 ward off some of the more devastating effects of this formidable virus.
|
|
|
Post by joeypotsandpans on Jul 25, 2020 22:15:42 GMT -5
Insulin..is an anti-inflammatory..and inhaled insulin goes to lungs..hmm An Afrezza user that had Covid-19...no ICU and feels fine..when in juxtaposition other diabetics are at a high rate of death.. This should send an alarm bell..I mean..it's sending one to me at least... Questions: 1. What insulins are diabetics on that died? 2. What insulins are diabetics on that had no ICU and are fine? Since Afrezza is used by a fraction of the diabetic community I would be shocked if no questionnaire has been sent directly to Afrezza users to even ask 1. Did you contract Covid-19? 2. Were you in ICU? 3. Are you over Covid-19? 4. What other drugs are you taking with Afrezza? 5. Are you using Afrezza alone? ect.. I dunno..is there a database today that shows a manufacturer..all drugs a patient is on..and if they got Covid-19 and what their outcomes where? I am wondering because Michael Castagna once said how surprized he was that Kaiser and insurances don't follow outcomes...ect..he was frustrated about that I recall.. So here we are on the flip side..Where is the outcomes data on Afrezza and Covid-19 infected populations? Anyways-Glad to see an Afrezza user getting over Covid-19 that is really good news! www.ncbi.nlm.nih.gov/pmc/articles/PMC3992527/#__sec9title
|
|
|
Post by joeypotsandpans on Jul 24, 2020 11:10:14 GMT -5
|
|
|
Post by joeypotsandpans on Jun 28, 2020 17:48:46 GMT -5
As a private Investor, my job is to invest my money and make money! Not to invest my money and lose my money! I work hard for my money and when I invest I expect to see a return. As a public company, Mannkind Corporation's job is to make their investors money. In this case, their job is to make me money. I invested in them, I will hold them accountable, and I will expect to see a return. So far, I'm underwater and holding my breath. I failed as an investor and Mannkind management has failed me. Like I said I haven't quit, I'm holding my breath, but Mike, I'll need oxygen soon, please don't quit me! They haven't failed me as a customer and for this reason alone a portion of my money continues to be invested in them, having said that, it doesn't mean you are precluded from other investments. It's the choices we make where accountability lies, I take full responsibility for my own actions and decisions after doing my own due diligence. You can read and choose to listen to others opinions etc., but at the end of the day it's the choices we make whether to remain invested. This has and remains a speculative investment, key word is speculative...high risk, high reward. If I wanted a conservative investment with expected returns I would be in a large cap with a stable history of dividends. The history of this investment is very indicative of what comes with a speculative investment. Thus why I have said in the past, it's a Rip Van Winkle stock, hopefully one day I wake up to a nice surprise but I don't watch it like a pot about to boil. Even MTOI says one day hopefully his daughter will wake up with a lot of money
|
|
|
Post by joeypotsandpans on Jun 24, 2020 12:24:20 GMT -5
Didn’t MC speak at 6 AM today? If so, Bob’s your uncle. Mnkd taking the entire market down! This was funny you old goat
|
|
|
Post by joeypotsandpans on Jun 22, 2020 12:44:44 GMT -5
I would think if there were to be any offering it would come at a price high enough to withstand any huge set back, the 200 day is a fair amount lower than the 200 week and should be in the rear view mirror while it starts to head up 😉 Why are you talking about an offering when Warrants are about to be exercised ($11M) and a pending $(12.5M) Payment? And if you let me dream......an EQUITY PARTNER for the PEDS Trial and eventually Type 2 Market. I was just responding to brotherm1 question...that's why I said "if" there were one, key word being if
|
|
|
Post by joeypotsandpans on Jun 22, 2020 11:46:13 GMT -5
Joey - Could an equity offering not put it below the 200 day? I would think if there were to be any offering it would come at a price high enough to withstand any huge set back, the 200 day is a fair amount lower than the 200 week and should be in the rear view mirror while it starts to head up 😉
|
|
|
Post by joeypotsandpans on Jun 22, 2020 10:52:46 GMT -5
Hovering around 2. That is an important threshold. hehe, look at the volume jump here over $2.00. MNKD hitting stops? added, side note for the board, triangles can be fast, I say this the larger triangle being worked here has a target of $7.50. To see price action like this makes the pattern more likely to hit. oh and joeypotsandpans! eyeballs please. A solid cross above the 200 week is a very telling confirmation with the accompanying volume, this is a long term trend change/move higher. There are some very exciting secular changes happening in the biotech spaces...just watching what's going on currently with the DNA/MRNA advances is spectacular. Technological advances are happening at light speed. MNKD is not immune to be involved with it and one can argue they were a little ahead of the curve and maybe getting noticed now. Again wake me @ $10
|
|